COMMUNIQUÉS West-GlobeNewswire

EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017

01/11/2017 - 12:30

Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital Conference Call to Review Results to be [...]

uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress

01/11/2017 - 12:00

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]

RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines

01/11/2017 - 12:00

RIZAPORT ® is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines A Prescription Drug User Fee Act (PDUFA) date is expected to be set by the FDA for the first half of 2018, if [...]

Enzymatica AB: Sales soar in third quarter

01/11/2017 - 08:00

Enzymatica Interim Report January-September 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017

01/11/2017 - 07:30

Reported sales increased by 2% to DKK 83.7 billion (3% in local currencies) Sales within diabetes and obesity care increased by 7% to DKK 69.7 billion (8% in local currencies). Sales of Tresiba ® increased by 117% to [...]

uniQure Announces Multiple Company Presentations at Upcoming November Conferences

31/10/2017 - 21:09

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 31, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, [...]

Prothena to Report Third Quarter 2017 Financial Results on November 7

31/10/2017 - 21:05

DUBLIN, Ireland, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017

31/10/2017 - 21:05

GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday [...]

Les données provisoires de Vascular Dynamics sur MobiusHD présentées à la conférence TCT montrent des réductions significatives de la pression artérielle systolique ambulatoire à échéance de six mois

31/10/2017 - 18:30

La société a lancé un essai pilote du MobiusHD aux États-Unis et en Europe MOUNTAIN VIEW, Californie, le 31 octobre 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc., une société privée de dispositifs médicaux qui [...]

Oxford BioMedica notes the sBLA submission to FDA for Kymriah(TM) in adult patients with r/r DLBCL

31/10/2017 - 17:02

Oxford BioMedica notes the sBLA submission to FDA for Kymriah(TM) in adult patients with r/r DLBCL Oxford, UK - 31 October 2017 : Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and [...]

New Analyses Reinforce Hemodynamic Benefits of Medtronic Evolut(TM) TAVR Platform in Intermediate Risk Aortic Stenosis Patients

31/10/2017 - 15:00

Presented at TCT, Evolut TAVR Platform Showcases Positive Clinical Outcomes in Patients Wanting to Return to More Active Lives DUBLIN and DENVER - October 31, 2017 - Medtronic plc (NYSE:MDT) today presented new clinical [...]

Novo Nordisk A/S - Share repurchase programme

31/10/2017 - 14:26

Bagsværd, Denmark, 31 October 2017 - On 9 August 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy

31/10/2017 - 13:00

WALTHAM, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

31/10/2017 - 13:00

PRESS RELEASE Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting (Oxford, UK and Conshohocken, US, 31 October 2017) [...]

ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November

31/10/2017 - 12:00

Geneva, Switzerland and Boston, MA - October 31, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Sanofi : Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma

31/10/2017 - 11:58

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma First [...]

Sanofi : Le dupilumab a permis de réduire significativement le recours aux corticoïdes et les crises d'asthme, et d'améliorer la fonction respiratoire, dans une étude de phase 3 portant sur des pe...

31/10/2017 - 11:58

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE: SNY) Le dupilumab a permis de réduire significativement le recours aux corticoïdes et les crises d'asthme, et d'améliorer la fonction respiratoire, dans une [...]

Clinical Decision Support System (CDSS) Market Worth $1,500 Million by 2022: Acumen Research and Consulting

31/10/2017 - 11:19

Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled " Clinical Decision Support System Market (Solutions: Integrated CDSS Solutions, Standalone CDSS [...]

Photocure ASA: Presentation of the third quarter 2017 results

31/10/2017 - 11:08

Photocure will present its third quarter report on Wednesday 8 November 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be Kjetil Hestdal, [...]